Clinical Trials Browser

INDUSTRY × Neoadjuvant Therapy × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT07149857 2026-05-08

CARTITUDE-10

Phase 2 Recruiting

60 enrolled

Plasma cell

Multiple Myeloma

NCT06587451 2026-02-24

Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy®

Phase 3 Terminated

52 enrolled

Dermatologic

Melanoma

NCT03636256 2023-08-14

Evaluation of NanoDoce® in Participants With Urothelial Carcinoma

Phase 1/2 Completed

36 enrolled 18 charts

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urogenital Neoplasms, Urologic Neoplasms

NCT00324727 2021-06-21

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

Phase 3 Completed

93 enrolled

Dermatologic

Uveal Melanoma, Melanoma, Neoplasm Metastasis

NCT02027428 2020-08-17

Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer

Phase 3 Completed

427 enrolled 29 charts

Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

NCT02326584 2018-05-09

A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML

Phase 1 Completed

116 enrolled

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00635245 2015-03-11

CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery

Phase 1 Withdrawn

Breast

Breast Neoplasms

Clinical Trials

MK-3475-01E